Toggle light / dark theme

LinkedIn, the Microsoft-owned social platform, has made a name for itself primarily as a platform for people looking to network and pick up knowledge for professional purposes, and for recruitment — a business that now has more 1 billion users. Now, to boost the time people are spending on the platform, the company is breaking into a totally new area: gaming.

TechCrunch has learned and confirmed that LinkedIn is working on a new games experience. It will be doing so by tapping into the same wave of puzzle-mania that helped simple games like Wordle find viral success and millions of players. Three early efforts are games called “Queens”, “Inference” and “Crossclimb.”

App researchers have started to find code that points to the work LinkedIn is doing. One of them, Nima Owji, said that one idea LinkedIn appears to be experimenting with involves player scores being organised by places of work, with companies getting “ranked” by those scores.

We use two 1D quasicondensates in a double potential well to realize a bosonic Josephson junction, a microscopic system that gives rise to interesting quantum phenomena resulting from the interplay of quantum tunneling and interaction. The multimode characteristics within the quasicondensates make the system suitable as a quantum field simulator. To prepare quantum states, we split a single condensate into two and, consequently, we witness the dynamical evolution of quantum fluctuations in the relative degree of freedom between the two split condensates. We demonstrate how to use these dynamics to effectively prepare more strongly correlated quantum states and how those influence spatial phase coherence.

Our work introduces innovative methods for engineering correlations and entanglement in the external degree of freedom of interacting many-body systems. It is a leap forward in understanding and harnessing quantum correlations, paving the way for exciting possibilities in quantum simulation research.

They treated three patients with recurrent glioblastoma using a variant of an existing CAR-T therapy, adding additional antibodies to the treatment — and the results were truly astounding.

According to the paper published in The New England Journal of Medicine, one patient saw their tumor decrease in size by 18.5% two days after the treatment, and by day 69, the tumor had decreased by 60.7%, while another saw their ‘tumor regress rapidly’, according to Mass General Brigham.

After the third patient was treated, an MRI showed that a single infusion had led to a ‘near-complete tumor regression’ in just five days.

The fabric of the cosmos, as we currently understand it, comprises three primary components: ‘normal matter,’ ‘dark energy,’ and ‘dark matter.’ However, new research is turning this established model on its head.

A recent study conducted by the University of Ottawa presents compelling evidence that challenges the traditional model of the universe, suggesting that there may not be a place for dark matter within it.

Dark matter, a term used in cosmology, refers to the elusive substance that does not interact with light or electromagnetic fields and is only identifiable through its gravitational effects.

Scientists have categorized different types of CRISPR systems into two classes based on how their Cas nucleases function. In class 1 (types I, III, and IV), different Cas proteins form a complex machinery to identify and cut foreign DNA; in class 2 CRISPR systems (types II, V, and VI), a single Cas protein effector recognizes and cleaves DNA.9

After characterizing CRISPR’s role as a defense mechanism in bacteria, researchers soon realized that they could harness this system for gene manipulation in any cell. All they needed to do was design a CRISPR gRNA sequence that bound to a specific DNA sequence and triggered the Cas nuclease, which would then cut precisely at that location. With CRISPR, researchers routinely knock out gene function by cutting out a DNA fragment, or they insert a desired genetic sequence into the genome by providing a reference DNA template along with the CRISPR components. While editing eukaryotic cells has been the focus for tackling diseases, many researchers now use CRISPR to edit bacterial communities.

“It’s almost like back to the beginning or back to the origins. There’s some irony in bringing CRISPR back to where it came from,” said Rodolphe Barrangou, a functional genomics researcher at North Carolina State University, who helped characterize the immune function of CRISPR and has been working with it for more than 20 years.